Naturally Independent Expo
CapsCanada

Eighth Annual NIE New Ingredient Awards Call for Entries

NPA


FDA Fails to Deliver Congressionally Mandated Report on CBD Regulations

by Shari Barbanel | February 25, 2020

The U.S. Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy within 120 days and provide an update of its progress after 60 days. The agency’s first report ...

NPA Exits Chapter 11 Bankruptcy

by Shari Barbanel | February 20, 2020

The Natural Products Association (NPA) announced that it will exit chapter 11 bankruptcy effective immediately. A judge granted NPA’s filing to dismiss the case after just over six months of court proceedings. “This was a business decision, it was the right thing to do, and it is an exciting day for NPA because we emerge stronger ...

NJ Lawmakers Propose Access to Financial Services for CBD Companies

by Nicholas Saraceno | February 13, 2020

Companies producing and selling hemp-derived CBD products would have access to essential banking services under new legislation introduced yesterday in the New Jersey State Senate. The legislation, introduced by State Sen. Robert W. Singer (R-NJ-30), would clarify that banks and credit unions will not be penalized by state regulators for working with legitimate hemp businesses. The ...

Senate Confirms Hahn as FDA Commissioner

by Shari Barbanel | December 16, 2019

In a 72-18 Senate vote, Stephen Hahn, MD, FASTRO was confirmed as the new head of the U.S. Food and Drug Administration (FDA), taking charge at a regulatory agency that oversees products ranging from complex cancer drugs, to food, cosmetics, tobacco and CBD. “We look forward to working with Dr. Hahn and his staff to ...

President Trump Nominates Stephen Hahn as FDA Commissioner

by Shari Barbanel | November 7, 2019

According to Politico, President Donald Trump announced last week that he will nominate Stephen Hahn, MD, FASTRO, a cancer specialist and hospital administrator, to lead the FDA (U.S. Food and Drug Administration). Trump had been rumored to make this selection for several months. If confirmed by the Senate, the top FDA post would mark Hahn’s first ...

CBD Usage Drops Sharply When Consumers Learn FDA Has No Safety Standards

by Shari Barbanel | October 23, 2019

In a warning sign for the burgeoning hemp and CBD industry, a new poll shows that 44 percent of Americans are less likely to use CBD products after learning that the U.S. Food and Drug Administration (FDA) has no standards in place to protect consumers, including 30 percent who say they would be far less ...

House Passes Hemp and Cannabis SAFE Banking Act

by Janet Poveromo | September 26, 2019

The Secure and Fair Enforcement Banking (SAFE Banking) Act of 2019, H.R. 1595, first introduced in 2017 and reintroduced in March 2019 by Rep. Ed Perlmutter (D-CO), was officially passed by the U.S. House of Representatives yesterday afternoon by a vote of 321 to 103. The hemp and cannabis industries have had to operate through ...

NPA Files For Bankruptcy

by Shari Barbanel | August 22, 2019

The Natural Products Association (NPA), which said it is the largest and oldest U.S. nonprofit dedicated to the natural products industry, filed for bankruptcy protection on August 19, citing six straight years of losses and a costly arbitration with a former chief financial officer. CEO and President Daniel Fabricant, PhD said in a filing with ...

FDA’s Request for Supplement Registration Doesn’t Unburden Industry, Says NPA

by Shari Barbanel | March 25, 2019

The Natural Products Association (NPA) recently asked Congress to reject the U.S. Food and Drug Administration’s (FDA) budget request for a product registration system for nutritional supplements, as it’s unclear of what value is added to the agency’s mission of promoting and protecting public health.      “The administration has been clear that they want to unburden ...

FDA Commissioner Gottlieb Resigning

by Shari Barbanel | March 11, 2019

On March 5, U.S. Food and Drug Administration (FDA) chief Scott Gottlieb announced his planned resignation, the Department of Health and Human Services (HHS) said, and plans to step down in one month. Gottlieb won bipartisan support for his efforts to curb the use of flavored e-cigarettes by youths, speed approval times for cheap generic ...

Don't Miss Out!

Sign up for Nutrition Industry Executive Digital Newsletter
Digital Newsletter
Subscribe to Nutrition Industry Executive Magazine
Nutrition Industry Executive Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listings:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!